Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beige mouse model for Mycobacterium avium complex disease.

× No keyword cloud information.

74 in total

1. Pathogenicity and virulence of atypical mycobacteria for experimental animals, with particular reference to pathological processes in the joints and tendon sheaths of rabbits.

Authors: H C ENGBAEK
Journal: Acta Tuberc Scand Date: 1961

2. Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines.

Authors: L E Bermudez; L S Young
Journal: J Infect Dis Date: 1991-06 Impact factor: 5.226

3. From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS.

Authors: B E Laughon; H S Allaudeen; J M Becker; W L Current; J Feinberg; J K Frenkel; R Hafner; W T Hughes; C A Laughlin; J D Meyers
Journal: J Infect Dis Date: 1991-08 Impact factor: 5.226

4. An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.

Authors: L E Bermudez; M Petrofsky; P Kolonoski; L S Young
Journal: J Infect Dis Date: 1992-01 Impact factor: 5.226

5. In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex.

Authors: C B Inderlied; P T Kolonoski; M Wu; L S Young
Journal: J Infect Dis Date: 1989-05 Impact factor: 5.226

6. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.

Authors: F Kuze
Journal: Am Rev Respir Dis Date: 1984-03

7. TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.

Authors: M H Cynamon; S P Klemens; C E Swenson
Journal: J Antimicrob Chemother Date: 1992-06 Impact factor: 5.790

8. Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.

Authors: L E Bermudez; C B Inderlied; P Kolonoski; M Petrofsky; L S Young
Journal: Antimicrob Agents Chemother Date: 1994-12 Impact factor: 5.191

9. Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients.

Authors: V M Reddy; K Parikh; J Luna-Herrera; J O Falkinham; S Brown; P R Gangadharam
Journal: Microb Pathog Date: 1994-02 Impact factor: 3.738

10. Cryptosporidium infections in inbred strains of mice.

Authors: F J Enriquez; C R Sterling
Journal: J Protozool Date: 1991 Nov-Dec

15 in total

Review 1. Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors: N B Harris; R G Barletta
Journal: Clin Microbiol Rev Date: 2001-07 Impact factor: 26.132

2. In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex.

Authors: C M Shoen; O Choromanska; R C Reynolds; J R Piper; C A Johnson; M H Cynamon
Journal: Antimicrob Agents Chemother Date: 1998-12 Impact factor: 5.191

3. Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice.

Authors: L Fattorini; Y Xiao; M Mattei; Y Li; E Iona; M L Ricci; O F Thoresen; R Creti; G Orefici
Journal: Antimicrob Agents Chemother Date: 1998-03 Impact factor: 5.191

4. Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium.

Authors: M Florido; R Appelberg; I M Orme; A M Cooper
Journal: Immunology Date: 1997-04 Impact factor: 7.397

5. Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.

Authors: M Brun-Pascaud; P Rajagopalan-Levasseur; F Chau; G Bertrand; L Garry; F Derouin; P M Girard
Journal: Antimicrob Agents Chemother Date: 1998-05 Impact factor: 5.191

6. Inhibition of tumor necrosis factor alpha alters resistance to Mycobacterium avium complex infection in mice.

Authors: S Bala; K L Hastings; K Kazempour; S Inglis; W L Dempsey
Journal: Antimicrob Agents Chemother Date: 1998-09 Impact factor: 5.191

7. Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection.

Authors: R G Kansal; R Gomez-Flores; I Sinha; R T Mehta
Journal: Antimicrob Agents Chemother Date: 1997-01 Impact factor: 5.191

8. Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.

Authors: L E Bermudez; P Kolonoski; L S Young
Journal: Antimicrob Agents Chemother Date: 1996-04 Impact factor: 5.191

9. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.

Authors: R T Mehta
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

10. Cellular immune response to pulmonary infections in HIV-infected individuals hospitalized with diverse grades of immunosuppression.

Authors: M J Miguez-Burbano; D Ashkin; A Rodriguez; R Duncan; M Flores; B Acosta; N Quintero; A Pitchenik
Journal: Epidemiol Infect Date: 2006-04 Impact factor: 2.451